Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 4Neoplasms 4Multiple Myeloma 2Frailty 2Fallopian Tube Neoplasms 2Urinary Bladder Neoplasms 1Postoperative Complications 1Lung Neoplasms 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Geriatric Assessment 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Sorafenib 20lenvatinib 18Hepatectomy 17Blood Specimen Collection 12Immune Checkpoint Inhibitors 11Liver Transplantation 9atezolizumab 8Surgical Procedures, Operative 7Radiofrequency Ablation 7Observation 7Bevacizumab 6regorafenib 5gadolinium ethoxybenzyl DTPA 5sintilimab 4donafenib 4camrelizumab 4Radiotherapy 4Magnetic Resonance Spectroscopy 4tislelizumab 3spartalizumab 3Polymerase Chain Reaction 3Neoadjuvant Therapy 3Mass Spectrometry 3Immunohistochemistry 3Doxorubicin 3Angiogenesis Inhibitors 3toripalimab 2pembrolizumab 2entecavir 2apatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Carcinoma, Hepatocellular × Geriatric Assessment × Clear all
NCT03894917 2026-01-08

Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

The University of Texas Health Science Center at San Antonio

Recruiting
84 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡